- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine
Total 2027 results
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Unknown
-
Merck Sharp & Dohme LLCRecruitingBreast NeoplasmsIsrael, United States, Taiwan, Hong Kong, Korea, Republic of, Switzerland
-
Advenchen Laboratories, LLCActive, not recruitingFallopian Tube Carcinoma | Cervical Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaKorea, Republic of, Spain, United States, United Kingdom, China, Italy
-
National Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Transitional Cell Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Clear... and other conditionsUnited States
-
Ruijin HospitalUnknown
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TTY BiopharmTerminatedBreast CancerSingapore
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Recurrent Breast Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Female Reproductive CancerUnited States
-
Southeastern Gynecologic OncologyOrtho Biotech, Inc.Completed
-
Sequus PharmaceuticalsCompletedHIV Infections | Sarcoma, KaposiUnited States
-
Sequus PharmaceuticalsCompletedHIV Infections | Sarcoma, KaposiUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Fudan UniversityRecruiting
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.UnknownHER2-positive Breast CancerChina
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
University of ArizonaTerminatedBreast CancerUnited States
-
Spanish Breast Cancer Research GroupSchering-PloughCompleted
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Endometrial CancerUnited States, Canada
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI); United States Department of DefenseCompleted
-
MedSIRRoche Pharma AG; ExperiorCompleted
-
ARCAGY/ GINECO GROUPCompleted
-
European Organisation for Research and Treatment...CompletedBreast CancerFrance, Spain, Netherlands, United Kingdom, Italy, Israel, Switzerland, Greece, Austria
-
National Cancer Institute (NCI)Completed
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Mixed Adenocarcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIC Uterine Corpus Cancer | Stage... and other conditionsUnited States
-
ImmunoGen, Inc.Gynecologic Oncology GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaUnited States, France, Canada, Spain, Switzerland, Belgium, Italy, United Kingdom, Ireland, Russian Federation, Bosnia and Herzegovina, Czechia, Serbia
-
NHS Greater Glasgow and ClydeBoehringer Ingelheim; Cancer Research UK; European Organisation for Research... and other collaboratorsUnknownOvarian Clear Cell Carcinoma | Endometrial Clear Cell CarcinomaUnited Kingdom
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
Yong ChenUnknownStage III Adult Soft Tissue SarcomaChina
-
AGC Biologics S.p.A.Completed
-
AGC Biologics S.p.A.CompletedOvarian CancerItaly, United Kingdom
-
University of LeicesterUnknownGastric Cancer | Esophageal CancerUnited Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute, NaplesCompleted
-
The Netherlands Cancer InstituteUnknownMetastatic Gastric Cancer | Adenocarcinoma of the Gastro-oesophageal JunctionNetherlands
-
Centocor, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Fudan UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedEndometrial CancerUnited States
-
South Eastern European Research Oncology GroupRoche Pharma AGUnknownBreast Cancer | MetastasisCroatia
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
The Netherlands Cancer InstituteActive, not recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingBreast Cancer | Hormone-receptor Positive Breast CancerChina
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruiting
-
Instituto do Cancer do Estado de São PauloFundação Faculdade de MedicinaTerminatedLocally Advanced HER2-negative Breast CancerBrazil
-
Fudan UniversityUnknown
-
TelikCompletedOvarian NeoplasmsUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingBreast Cancer | Efficacy | Safety | Liposomal Doxorubicin | Postoperative Adjuvant TreatmentChina
-
Peking University People's HospitalHunan Cancer Hospital; Peking University Cancer Hospital & Institute; Peking... and other collaboratorsUnknown